- WhizAI recently announced that they have raised $8 million in series A financing. These are the details.
WhizAI — the first and only purpose-built augmented consumer platform for the life sciences industry — recently announced that they have raised $8 million in series A financing. Vertical Venture Partners led this round and existing investors also participated. This latest funding round brings the total amount raised by the company to over $15 million.
WhizAI is transforming how top global pharma companies use analytics for increasing the top line and reduce the bottom line. And they help large and mid-sized pharma reduce TCO by about 50% while modernizing and streamlining legacy analytics systems through intelligent automation. And they also empower business users in sales, commercial ops, marketing, R&D, and supply chain through contextual, actionable insights without month-long wait times and complex software that needs high-level technical skills. Plus they are helping improve business outcomes by identifying key opportunities, eliminating operational inefficiencies, and streamlining the analytics ecosystem
KEY QUOTES:
“We are fundamentally changing the way analytics is done in life sciences by helping our customers keep pace with large scale data, on-demand analytics, and timely insights. The future of analytics is augmented via AI to enable everyone to be insights-driven. We are delighted that our investors share this vision and support us to fulfill our mission. We will be using this investment to expand our footprint in the US and Europe and invest in all aspects of the business.”
— Rohit Vashisht, co-founder and CEO, WhizAI
“BI is another horizontal platform technology that needs to move to vertical-specific for customers to get the full value. Predictive and prescriptive analytics, the next phase of customer value from BI, cannot be fully realized without a vertical approach. This move from horizontal platforms to vertical solutions is the core theme of our venture fund. This vertical approach combined with a strong management team with deep BI experience makes this an ideal investment for Vertical Venture Partners.”
— David Schwab, Founder and Managing Director at Vertical Venture Partners
